Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
High rates of diagnostic discordance and co-pathology: Insights into PSP from the NACC dataset.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Popli Tanav, Pal Subhamoy, Gregoire Allyson, Reader Jonathan M, Passamani Alexis, Bakulski Kelly M, Bhaumik Arijit, Pinarbasi Emile, Paulson Henry, Cook Maher Amanda
Аннотация
INTRODUCTION: Clinical features associated with accurate clinico-pathologic correlation within cognitive-predominant progressive supranuclear palsy (PSP) presentations have not been extensively studied. We identified features affecting PSP diagnosis within the National Alzheimer's Coordinating Center (NACC) dataset, a cognitive/behavioral research database.
METHODS: Autopsied NACC participants with clinical or neuropathologic PSP diagnoses were categorized by diagnostic modality (Clinical-only, Neuropathology-only, both). Group differences in clinical, demographic, neuropsychologic, and neuropathologic features were assessed.
RESULTS: Only 38.8% of neuropathologically identified PSP had clinical PSP diagnosis while 63.5% of clinically identified PSP had PSP pathology. Neuropathology-only cases had fewer motor symptoms and better processing speed/executive functioning than the Clinical-Neuropathology group. Nearly 70% demonstrated co-neuropathologies including Alzheimer-type, Lewy body, and corticobasal degeneration pathologies.
DISCUSSION: Within NACC, discordant clinical and neuropathologic PSP diagnoses highlight the heterogeneity of PSP presentation, possibly driven by reliance on "classic" ante mortem symptoms. Further studies should assess the impact of co-pathology on clinical neurodegenerative disease presentations.
HIGHLIGHTS: A high rate of clinico-pathologic PSP diagnostic discordance is seen within NACC. Cases without clinical PSP diagnosis had fewer classic motor and cognitive symptoms. Isolated PSP neuropathology is uncommon, with nearly 70% showing co-neuropathology.
METHODS: Autopsied NACC participants with clinical or neuropathologic PSP diagnoses were categorized by diagnostic modality (Clinical-only, Neuropathology-only, both). Group differences in clinical, demographic, neuropsychologic, and neuropathologic features were assessed.
RESULTS: Only 38.8% of neuropathologically identified PSP had clinical PSP diagnosis while 63.5% of clinically identified PSP had PSP pathology. Neuropathology-only cases had fewer motor symptoms and better processing speed/executive functioning than the Clinical-Neuropathology group. Nearly 70% demonstrated co-neuropathologies including Alzheimer-type, Lewy body, and corticobasal degeneration pathologies.
DISCUSSION: Within NACC, discordant clinical and neuropathologic PSP diagnoses highlight the heterogeneity of PSP presentation, possibly driven by reliance on "classic" ante mortem symptoms. Further studies should assess the impact of co-pathology on clinical neurodegenerative disease presentations.
HIGHLIGHTS: A high rate of clinico-pathologic PSP diagnostic discordance is seen within NACC. Cases without clinical PSP diagnosis had fewer classic motor and cognitive symptoms. Isolated PSP neuropathology is uncommon, with nearly 70% showing co-neuropathology.